Filing Flows › VitaNova Life Sciences (VNOV) › Q4 FY26 › vs Q3 FY26
VitaNova Life Sciences (VNOV) Q4 FY26 vs Q3 FY26 (quarter over quarter)
VitaNova Life Sciences's revenue rose $1.1M (+152%) from $710K in Q3 FY26 to $1.8M in Q4 FY26.
VitaNova Life Sciences, Q4 FY26: revenue $1.8M (-9% year over year), operating margin -6.2%, net earnings $18K, operating cash flow $428K. The chart draws each line against Q3 FY26, the increases inside each band.
Every line
| Line | Q4 FY26 | Q3 FY26 | Change | % |
|---|---|---|---|---|
| Revenue | $1.8M | $710K | $1.1M | +152% |
| Income tax benefit | $125K | −$91K | $216K | — |
| Costs & expenses | $1.9M | $754K | $1.2M | +154% |
| Operating costs | $1.9M | $663K | $1.2M | +186% |
| Net earnings | $18K | −$44K | $62K | — |
| Cost of revenue | $1.5M | $393K | $1.1M | +287% |
| General & admin | $328K | $220K | $109K | +50% |
| Other operating costs | $46K | $50K | −$4K | -8% |
| Operating cash sources | $428K | −$90K | $519K | — |
| Share-based compensation | $179K | $0 | $179K | — |
| Working capital & other | $231K | −$46K | $277K | — |
| Operating cash flow | $428K | −$90K | $519K | — |
Questions
How much did VitaNova Life Sciences's revenue grow quarter over quarter in Q4 FY26?
VitaNova Life Sciences's revenue rose $1.1M (+152%) from $710K in Q3 FY26 to $1.8M in Q4 FY26.